Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2009
Canonical Wnt signaling negatively regulates platelet functionBrian M Steele, Matthew T Harper, Iain C Macaulay, et al.European Heart Journal|April 21, 2006
Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppressionTomas G Neilan, Davinder S Jassal, Michael F Scully, et al.Echo Research and Practice|February 22, 2023
The use of deformation imaging in the assessment of patients pre and post transcatheter aortic valve implantationMark Coyle, Gerard King, Kathleen Bennett, et al.Circulation|April 20, 2011
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease TrialStephen D Wiviott, Marcus D Flather, Michelle L O'Donoghue, et al.EMBO Molecular Medicine|August 22, 2013
Macrophage PPAR gamma Co-activator-1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acidCathal McCarthy, Nora T Lieggi, Denis Barry, et al.Irish Journal of Medical Science|July 9, 2022
Intravascular lithotripsy-assisted PCI for severely calcified coronary lesions: evaluating the impact on quality of life and outcomesAnthony J Buckley, John P McCormick, James Carey, et al.Circulation|April 20, 2011
Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes TrialMichelle L O'Donoghue, Deepak L Bhatt, Stephen D Wiviott, et al.Atherosclerosis|December 20, 2017
Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)Nina S McCarthy, Ciara Vangjeli, Praveen Surendran, et al.The American Journal of Cardiology|November 11, 2008
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial)Herbert D Aronow, Robert M Califf, Robert A Harrington, et al.Blood|November 20, 2012
Canonical Wnt signaling in megakaryocytes regulates proplatelet formationIain C Macaulay, Jonathan N Thon, Marloes R Tijssen, et al.Pageof 8